Robert J. Behrens
Robert J. Behrens publishes mostly in Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer and Cancer Treatment and Pharmacology.
- World rank
- #1,118,069 of 7,710,434 ranked researchers
- Rank in United States
- #361,122 of 1,627,098
- Works
- 61
- Citations
- 1.3k
- Citations per work
- 21.7
What does Robert J. Behrens research?
Robert J. Behrens's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3253.1%
- Medicine3253.1%
- Everything else2235.8%
- Life Sciences46.1%
- Social Sciences35.0%
- 1Oncology32% of their works
- 2Pathology and Forensic Medicine8% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Surgery6% of their works
- 5Cancer Research6% of their works
- 6Economics and Econometrics5% of their works
Research topics
Which keywords describe Robert J. Behrens's research?
The keywords of their largest research topics: Chemotherapy, Molecular Subtypes, Adjuvant Chemotherapy, Neoadjuvant Therapy, Cetuximab, KRAS Mutations, Microsatellite Instability and Molecular Characterization.
- PD-1 and PD-L1
- Gene Expression
- Rectal Cancer
- Mutational Signatures
- Surgical Complications
- Taxanes
- Tumor Microenvironment
- Molecular Characterization
- KRAS Mutations
- Neoadjuvant Therapy
- Molecular Subtypes
- Chemotherapy
- Adjuvant Chemotherapy
- Cetuximab
- Microsatellite Instability
- Clinical Practice Guidelines
- Chemotherapy-Induced Peripheral Neuropathy
- Pancreatic Cancer
- Cancer Genomics
- Preoperative Chemoradiotherapy
- Breast Tumours
- Immune Checkpoint Blockade
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy232 topics
- Molecular Subtypes212 topics
- Adjuvant Chemotherapy202 topics
- Neoadjuvant Therapy183 topics
- Cetuximab161 topic
- KRAS Mutations161 topic
- Microsatellite Instability141 topic
- Molecular Characterization141 topic
- Clinical Practice Guidelines112 topics
- Tumor Microenvironment112 topics
- Chemotherapy-Induced Peripheral Neuropathy81 topic
- Taxanes81 topic
- Pancreatic Cancer71 topic
- Surgical Complications71 topic
- Cancer Genomics61 topic
- Mutational Signatures61 topic
- Preoperative Chemoradiotherapy61 topic
- Rectal Cancer61 topic
- Breast Tumours51 topic
- Gene Expression51 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
Where does Robert J. Behrens work?
Robert J. Behrens's main affiliation in the publication record is Iowa Oncology Research Association, United States.
How many publications and citations does Robert J. Behrens have?
OpenAlex counts 61 works and 1,322 citations for Robert J. Behrens, an h-index of 19, ranking #1,118,069 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert J. Behrens. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.